Table 1 Patient characteristics

From: Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer

Patient characteristics

No. of patients ( N =64)

%

Age, years

 

’

 Median (range)

55 (33–74)

 

Sex

  

 Female

17

27

 Male

47

73

ECOG status

  

 0

3

5

 1

58

90

 2

3

5

First-line regimen

  

 Paclitaxel/CDDP

8

14

 Docetaxel/CDDP

33

50

 EDP

23

36

Organ involved

  

 Lymph nodes

34

41

 Liver

29

35

 Peritoneum

6

7

 Ovary

5

6

 Others

4

5

  1. Others: pancreas (two), bone (two), lung (one), adrenal (one), uterus (one), ureter (one).
  2. CDDP, cisplatin; EDP, epirubicin/docetaxel/cisplatin.
Back to article page